Latest News
- January 08, 2026Official press release: CBCC Global Research is now REV Clinical
- November 18, 2025ANDA application for Bimatoprost ophthalmic solution received Marketing Authorization from the USFDA!
- November 12, 2025ANDA application for Risperidone extended-release injectable suspension has received Marketing Authorization from the USFDA!
- October 30, 2025Accelerating Clinical Research!
- September 12, 2025Join CBCC at CPHI Frankfurt 2025
January 08, 2026
Official press release: CBCC Global Research is now REV Clinical
We’re excited to share today’s official press release announcing that CBCC Global Research is now REV Clinical, a new name that reflects the next chapter of growth while building on decades of experience in clinical research. REV reflects a continued focus on Reliability, Excellence, and Velocity.
🔗 Read the full press release: https://lnkd.in/ev2jbTdE
🌐 Visit the new website: https://lnkd.in/e7psZZQH
hashtagClinicalResearch hashtagClinicalTrials hashtagLifeSciences
Manoj Vyas Jaimeen Vanparia Sudhir D. Sanjeev Ganatra Dr. Sandeep Singh Nikhil Gandhi Harakh Shah, PMP® Tapan Shah Kinnari Gandhi RQAP-GCP Nikunj Patel Ankit Pandav Devang Pandya Jay Vyas Udayan Vyas Ajit Upadhyaya